Suppr超能文献

两次移植完全匹配肾脏的长期意外后果:两例报告

Long-term unexpected consequence of two kidney transplants with full-match grafts: a report of two cases.

作者信息

Tatar Erhan, Uslu Adam, Aykas Ahmet, Sahin Tamer

机构信息

Department of Nephrology and Transplantation Center, Izmir Bozyaka Education and Research Hospital Izmir, Turkey.

Department of General Surgery and Transplantation Center, Izmir Bozyaka Education and Research Hospital Izmir, Turkey.

出版信息

Int J Clin Exp Med. 2015 Jun 15;8(6):10074-80. eCollection 2015.

Abstract

HLA typing is the cornerstone of kidney transplantation. Here, we present two full-match kidney transplants with early uneventful course but late c4d-mediated rejection and recurrent pauce-immune necrotizing crescentic glomerulonephritis, as each in one. Case 1: A 49 years old Caucasian female patient, received a six-matched cadaveric kidney and had nonspecific changes in 6th and 12th month protocol biopsies. The first and third year serum creatinin value was 1.8 and 2.0 mg/dl. Immunosuppressive drugs were gradually reduced due to recurrent infections at the 3rd year. She admitted with allograft dysfunction and serum creatinin 5.8 mg/dl. Kidney biopsy of graft dysfunction at the 4th year was diagnosed C4d-mediated rejection. Case 2: A 61 years old Caucasian female patient received a HLA-identical kidney 8.5 years ago from her sibling had a primary vasculitis mediated necrotizing crescentic glomerulonephritis. Her serum creatinin values in the 1st and 8th years were 1.3 and 1.7 mg/dl. In recent years, immunosuppressive dosage has been gradually reduced due to recurrent lower respiratory tract infections. She admitted with hematuria, purpuric rash, dyspnea. and serum creatinin 5.7 mg/dl. Renal biopsy revealed necrotizing crescentic glomerulonephritis. The patient was treated with pulse steroid, double filtration plasmapheresis and rituximab. She is being followed with a functioning graft and with serum creatinin 2.0 mg/dl. In case of recurrent infection, immunosuppressive drugs should be modified cautiously even in patients with full-match grafts to prevent late acute rejection or recurrence of the primary disease.

摘要

人类白细胞抗原(HLA)分型是肾移植的基石。在此,我们报告两例全匹配肾移植病例,早期过程顺利,但后期出现C4d介导的排斥反应和复发性少免疫性坏死性新月体性肾小球肾炎,各1例。病例1:一名49岁的白种女性患者,接受了一个六抗原匹配的尸体肾,在第6个月和第12个月的方案活检中出现非特异性变化。第1年和第3年的血清肌酐值分别为1.8和2.0mg/dl。由于第3年反复感染,免疫抑制药物逐渐减量。她因移植肾功能不全和血清肌酐5.8mg/dl入院。第4年对移植肾功能不全进行肾活检,诊断为C4d介导的排斥反应。病例2:一名61岁的白种女性患者8.5年前从其同胞处接受了一个HLA相同的肾脏,患有原发性血管炎介导的坏死性新月体性肾小球肾炎。她第1年和第8年的血清肌酐值分别为1.3和1.7mg/dl。近年来,由于反复下呼吸道感染,免疫抑制剂量逐渐减少。她因血尿、紫癜性皮疹、呼吸困难和血清肌酐5.7mg/dl入院。肾活检显示坏死性新月体性肾小球肾炎。该患者接受了脉冲类固醇、双重滤过血浆置换和利妥昔单抗治疗。目前她的移植肾功能良好,血清肌酐2.0mg/dl,正在接受随访。对于复发性感染的患者,即使是移植肾全匹配的患者,也应谨慎调整免疫抑制药物,以防止晚期急性排斥反应或原发性疾病的复发。

相似文献

3
Evaluation of late antibody-mediated rejection (C4d-mediated rejection): a single-center experience.
Exp Clin Transplant. 2015 Apr;13 Suppl 1:259-62. doi: 10.6002/ect.mesot2014.p67.
4
A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
Clin Transplant. 2009 Aug;23 Suppl 20:23-6. doi: 10.1111/j.1399-0012.2009.01004.x.
5
Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Transplantation. 1998 Jan 27;65(2):224-8. doi: 10.1097/00007890-199801270-00014.
6
Evaluation of Indication Biopsies ≥5 Years After Kidney Transplant: A Single-Center Experience.
Exp Clin Transplant. 2017 Feb;15(Suppl 1):265-268. doi: 10.6002/ect.mesot2016.P132.
7
Treatment of acute antibody-mediated rejection using bortezomib: a case report.
Nephrology (Carlton). 2015 Jul;20 Suppl 2:86-9. doi: 10.1111/nep.12459.
10
Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.
Nephrology (Carlton). 2015 Jul;20 Suppl 2:61-5. doi: 10.1111/nep.12465.

本文引用的文献

1
Evaluation of late antibody-mediated rejection (C4d-mediated rejection): a single-center experience.
Exp Clin Transplant. 2015 Apr;13 Suppl 1:259-62. doi: 10.6002/ect.mesot2014.p67.
3
Late kidney dysfunction in a kidney transplant recipient.
Clin J Am Soc Nephrol. 2014 Mar;9(3):590-7. doi: 10.2215/CJN.07390713. Epub 2013 Dec 26.
4
Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant.
Transpl Int. 2013 Dec;26(12):1225-31. doi: 10.1111/tri.12203. Epub 2013 Oct 18.
5
Recurrence from primary and secondary glomerulopathy after renal transplant.
Transpl Int. 2012 Aug;25(8):812-24. doi: 10.1111/j.1432-2277.2012.01483.x. Epub 2012 Apr 16.
6
Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
Nephrology (Carlton). 2012 Apr;17 Suppl 1:16-9. doi: 10.1111/j.1440-1797.2012.01586.x.
7
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.
Am J Transplant. 2012 Feb;12(2):388-99. doi: 10.1111/j.1600-6143.2011.03840.x. Epub 2011 Nov 14.
9
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905.
10
Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo.
Clin Transplant. 2009 Aug;23 Suppl 20:49-53. doi: 10.1111/j.1399-0012.2009.01010.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验